TLDR
- SBEV jumps 65% after Splash files its NYSE American compliance plan.
- Splash shares rally as compliance update lifts market activity around SBEV.
- SBEV holds strong gains despite pullback from sharp midday price spike.
- Splash continues cannabinoid wellness deal talks after Medterra LOI expiry.
- Splash targets NYSE compliance while reviewing strategic wellness deals.
Splash Beverage Group (SBEV) shares jumped sharply after the company updated the market on its NYSE American compliance process. SBEV traded at $0.2341, up 65.53%, after a midday spike near $0.38 faded. However, the stock still held strong gains as traders assessed the company’s latest corporate update.
Splash Beverage Group, Inc., SBEV
SBEV Rallies After Compliance Plan Submission
Splash Beverage Group said it submitted its compliance plan to NYSE American on May 28, 2026. The plan outlined steps management has taken and intends to take to regain compliance. Moreover, the company said it continues to engage with NYSE American staff.
The compliance issue followed an April 29, 2026, notice from NYSE Regulation. The notice stated that Splash failed to meet certain continued listing standards tied to stockholders’ equity. Besides, the company had previously disclosed the matter on May 5, 2026.
If NYSE American accepts the plan, Splash could continue its compliance efforts during a cure period. That period could run through January 29, 2027, under the exchange process. Management said it remains focused on keeping the company’s NYSE American listing.
Strategic Review Continues After Medterra LOI Expiry
Splash also updated the market on its strategic transaction process. The company said its non-binding Letter of Intent with Medterra CBD expired on May 4, 2026. The expired agreement did not stop Splash from reviewing other possible deals.
The company said the earlier Letter of Intent carried a non-exclusive structure. Splash continued to assess other strategic opportunities after the agreement expired. Management now holds discussions with several possible transaction counterparties.
Splash said it has advanced early talks with selected parties. The company uses several factors to assess potential deals, including strategic fit and capital structure. It considers long-term shareholder value and ways to limit dilution.
Company Targets Cannabinoid Wellness Platform
Splash continues to position its business toward the cannabinoid wellness sector. The company said the sector presents opportunities for consolidation, brand growth, and platform building. It also cited evolving federal rules that support parts of the industry.
The company wants to use its public company structure to support established operators and brands. Its focus remains on federally compliant hemp-derived cannabinoid products. However, broader cannabinoid wellness categories would still require regulatory and exchange approvals.
Interim Chief Executive Officer Brady Cobb said Splash continues to make progress across several areas. He said the compliance plan marked an important step in the company’s process. He also said the strategic review remains active and focused on long-term value.
Splash also disclosed a going concern note in its 2025 audited financial statements. The company included that statement in its Form 10-K filed on April 15, 2026. The disclosure satisfies NYSE American requirements and does not amend prior financial filings.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
